Sectors

VTRS
Viatris Inc.
16.28
3 x 16.30
1 x 16.72
bid
ask
+
0.00
0.00%
1 @ 04:00 PM
16.30 +0.02 (0.12%)
Ytd30.76%
1y65.11%
16.14
day range
16.57
9.43
52 week range
18.39
Open16.26Prev Close16.28Low16.14High16.57Mkt Cap18.96B
Vol13.87MAvg Vol10.22MEPS2.52P/E6.46Forward P/E6.17
Beta0.89Short Ratio4.65Inst. Own89.83%Dividend0.48Div Yield2.92
Ex Div Date08-21Earning08-0650-d Avg16.55200-d Avg14.151yr Est18.50

VTRS News

Viatris Inc. (VTRS) Q2 2026 Earnings Call Transcript
seekingalpha.com
Viatris Inc. (VTRS) Q2 2026 Earnings Call Transcript

Viatris Inc. (VTRS) Q2 2026 Earnings Call Transcript

Viatris Inc (VTRS) Shares Fall 7.6% -- GF Value Says Still Overvalued
gurufocus.com
Viatris Inc (VTRS) Shares Fall 7.6% -- GF Value Says Still Overvalued

On August 06, 2026, Viatris Inc (VTRS) shares fell 7.6%, closing at $16.29. Over the past year, the

Viatris Sharpens Focus with Divestiture, Hikes 2026 Outlook
benzinga.com
Viatris Sharpens Focus with Divestiture, Hikes 2026 Outlook

Harrow Inc. (NASDAQ:HROW) on Thursday agreed to acquire Tyrvaya (varenicline solution) nasal spray 0

VTRS Q2 Earnings Beat, Revenues Rise 5% as Greater China Sales Jump
zacks.com
VTRS Q2 Earnings Beat, Revenues Rise 5% as Greater China Sales Jump

Viatris tops Q2 earnings and revenue estimates as Greater China sales surge 21%, helping lift result

Compared to Estimates, Viatris (VTRS) Q2 Earnings: A Look at Key Metrics
zacks.com
Compared to Estimates, Viatris (VTRS) Q2 Earnings: A Look at Key Metrics

Although the revenue and EPS for Viatris (VTRS) give a sense of how its business performed in the qu

Viatris (VTRS) Beats Q2 Earnings and Revenue Estimates
zacks.com
Viatris (VTRS) Beats Q2 Earnings and Revenue Estimates

Viatris (VTRS) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Esti

gurufocus.com
Is Viatris Inc (VTRS) Worth the Investment After Q2 Earnings? EPS at $0.69, Revenue of $3,756.8 Mill

Viatris Inc (VTRS) released its 8-K filing on August 6, 2026, detailing its financial results for th

Viatris Reports Second-Quarter 2026 Financial Results
prnewswire.com
Viatris Reports Second-Quarter 2026 Financial Results

Delivers Total Revenues of $3.8 Billion, Representing 5% Reported Growth Compared to Second Quarter

Viatris (VTRS) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
zacks.com
Viatris (VTRS) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Beyond analysts' top-and-bottom-line estimates for Viatris (VTRS), evaluate projections for some of

Viatris Gears Up to Report Q2 Earnings: What's in the Cards?
zacks.com
Viatris Gears Up to Report Q2 Earnings: What's in the Cards?

VTRS readies Q2 results as growth in key markets and brands may offset manufacturing and pricing hea

Viatris Announces Quarterly Dividend
prnewswire.com
Viatris Announces Quarterly Dividend

PITTSBURGH, Aug. 4, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that on August

Viatris (VTRS) Q2 Earnings Preview: What's in the Cards?
zacks.com
Viatris (VTRS) Q2 Earnings Preview: What's in the Cards?

Viatris (VTRS) doesn't possess the right combination of the two key ingredients for a likely earning

Viatris Receives U.S. FDA Approval for Gwyn Lo™, a Once-Weekly Contraceptive Patch
prnewswire.com
Viatris Receives U.S. FDA Approval for Gwyn Lo™, a Once-Weekly Contraceptive Patch

New Patch Will Provide Low-Dose Estrogen Combined Hormonal Contraceptive Option Approval Marks an Im

Trump's generic drug tariffs: What they could mean for medicine prices, manufacturers and supply
cnbc.com
Trump's generic drug tariffs: What they could mean for medicine prices, manufacturers and supply

Trump plans tariffs of up to 200% on imported generic drugs after a two-year grace period aimed at e

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
benzinga.com
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividen

Investors turn to dividend-yielding stocks during market turbulence. Benzinga's Analyst Stock Ra

Why Viatris (VTRS) is a Top Value Stock for the Long-Term
zacks.com
Why Viatris (VTRS) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

VTRS or DHR: Which Is the Better Value Stock Right Now?
zacks.com
VTRS or DHR: Which Is the Better Value Stock Right Now?

Investors interested in Medical Services stocks are likely familiar with Viatris (VTRS) and Danaher

Should Value Investors Buy Viatris (VTRS) Stock?
zacks.com
Should Value Investors Buy Viatris (VTRS) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now
247wallst.com
3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now

Healthcare has been an unloved corner of the market in 2026, but that neglect has created a rare set

Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?
fool.com
Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?

Growth premium vs. value recovery, one trades at 33x forward earnings while the other navigates debt

Viatris (VTRS) is a Great Momentum Stock: Should You Buy?
zacks.com
Viatris (VTRS) is a Great Momentum Stock: Should You Buy?

Does Viatris (VTRS) have what it takes to be a top stock pick for momentum investors? Let's find out

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
benzinga.com
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividen

Investors turn to dividend-yielding stocks in turbulent markets. Benzinga offers latest analyst rati

benzinga.com
'Health Officials Close To U.S. Secretary Kennedy Explored Ban Of Some Widely Used Antidepressants'

Health officials explored restricting specific antidepressants among SSRI drugs-sources

benzinga.com
FDA Takes Step Forward on Testosterone Therapy for Men

https://www.fda.gov/news-events/press-announcements/fda-takes-step-forward-testosterone-therapy-men

Earnings Scheduled For February 26, 2026
benzinga.com
Earnings Scheduled For February 26, 2026

Earnings Scheduled For November 6, 2025
benzinga.com
Earnings Scheduled For November 6, 2025

S&P 500 Losers: 22 Stocks With Negative Returns Over Past 10 Years, And This One's Getting The Boot
benzinga.com
S&P 500 Losers: 22 Stocks With Negative Returns Over Past 10 Years, And This One's Getting The Boot

The S&P 500 Index is up over 200% over the past decade, but 22 stocks have declined during that

benzinga.com
Earnings Scheduled For August 7, 2025

benzinga.com
Earnings Scheduled For May 8, 2025

benzinga.com
Earnings Scheduled For February 27, 2025

benzinga.com
Earnings Scheduled For February 28, 2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a

benzinga.com
Tech Sell-Off Triggers Market Reset: Value Stocks Reach 7-Month High Versus Growth

U.S. stock market suffered worst start in two decades, tech sell-off led to cautious investor shift

benzinga.com
Earnings Scheduled For November 7, 2023

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings

benzinga.com
Earnings Scheduled For August 7, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report quarterly loss a

benzinga.com
Earnings Scheduled For May 8, 2023

Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 pe

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2023

benzinga.com
Earnings Scheduled For February 27, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly ear

benzinga.com
Earnings Scheduled For November 7, 2022

Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quar

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 1076 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 507 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  On Monday, 429 stocks made new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 529 companies set new 52-week lows.

benzinga.com
Earnings Scheduled For August 8, 2022

  Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings fo

benzinga.com
Earnings Scheduled For May 9, 2022

  Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quar

benzinga.com
Earnings Scheduled For February 28, 2022

  Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to repo

benzinga.com
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, I

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched

benzinga.com
Earnings Scheduled For November 8, 2021

  Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report q

benzinga.com
Earnings Scheduled For May 10, 2021

  Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its fir

cnn.com
Incyte Corporation

INCY is trading near the top of its 52-week range and above its 200-day simple moving average. Price

finance.yahoo.com
Viatris Inc. (VTRS) Latest Stock News & Headlines - Yahoo Finance

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and d